10-K: BWX Technologies Reports Increased Backlog and Revenue for Fiscal Year 2024, Plans Strategic Acquisitions

BWX Technologies (BWXT) reports increased revenue and backlog for FY2024, driven by growth in both Government and Commercial Operations, and announces strategic acquisitions to expand capabilities.

Summary

• BWX Technologies, Inc. (BWXT) reported an 8.3% increase in consolidated revenues for the year ended December 31, 2024, reaching $2.704 billion compared to $2.496 billion in 2023.
• The company's backlog increased to $4.843 billion at December 31, 2024, up from $3.998 billion in the previous year.
• Government Operations revenue increased by 7.5% to $2.183 billion, driven by higher volume in nuclear component manufacturing and growth in advanced technologies.
• Commercial Operations revenue increased by 12.4% to $524 million, driven by higher revenues in nuclear components, medical radioisotopes, fuel handling, and fuel fabrication.
• Operating income decreased slightly to $380.6 million in 2024 from $383.1 million in 2023, with increases in segment operating income offset by higher corporate expenses.
• The company completed the acquisition of Aerojet Ordnance Tennessee, Inc. (A.O.T) on January 3, 2025, and plans to acquire Kinectrics, Inc. in mid-2025.
• BWXT expects to recognize approximately 48% of its backlog revenue by the end of 2025.
• The company's effective tax rate was 19.0% for 2024, lower than the U.S. corporate income tax rate of 21% due to increased benefits from U.S. federal research and development tax credits.

Sentiment

Score: 7

Explanation: The document presents a generally positive outlook with increased revenue and backlog, strategic acquisitions, and a focus on growth. However, there are also risks and uncertainties related to government funding, economic conditions, and operational factors, preventing a higher score.

Positives

• The U.S. Navy's 30-year shipbuilding plan indicates growth in nuclear-powered submarines and aircraft carrier procurement.
• BWXT is well-positioned to participate in the ongoing cleanup, operation, and management of critical government-owned nuclear sites.
• The company is exploring growth strategies through strategic investments and acquisitions.
• BWXT has a strong focus on human capital management, including employee development, diversity and inclusion, and health and safety.
• The company maintains a captive insurance subsidiary to support its operations.

Negatives

• Consolidated operating income decreased slightly to $380.6 million in 2024 from $383.1 million in 2023 due to an increase in unallocated corporate expenses.
• The company relies on U.S. Government contracts for a substantial percentage of its revenue, which are subject to continued appropriations and potential termination.
• Demand for the company's products and services is vulnerable to economic downturns and the competitiveness of alternative energy sources.
• The company is subject to risks associated with contractual pricing, including the risk that actual costs exceed estimated costs on fixed-price contracts.
• The company's operations in foreign countries expose it to currency, political, and trade risks, including tariffs and trade barriers.

Risks

• Reductions in U.S. Government funding could adversely impact the company's operating results and cash flows.
• The company is subject to security threats, including physical and cybersecurity threats, which could disrupt its business.
• Actual or threatened public health epidemics, pandemics, or outbreaks, such as COVID-19, could have a material adverse effect on the company's business and results of operations.
• The company relies on intellectual property law and confidentiality agreements to protect its intellectual property, and failure to do so could adversely affect its business.
• The loss of, or the inability to attract and retain, qualified personnel could have a material adverse effect on the company's business.
• The company relies on a limited number of suppliers, including single-source suppliers, which could adversely affect its revenues and operating results.
• The company's business strategy includes acquisitions and strategic investments to support its growth, which can create certain risks and uncertainties.
• The company conducts a portion of its operations through joint venture entities, over which it may have limited ability to influence.
• The company recognizes a large portion of its revenue on an over time basis which could result in volatility in its results of operations.
• The company is involved in a number of legal proceedings, and the outcome of litigation and other contingencies cannot be predicted with certainty.
• The company's nuclear operations subject it to various environmental, regulatory, financial and other risks.
• Environmental, social and governance matters and any related reporting obligations may impact the company's business.

Future Outlook

BWXT expects to recognize approximately 48% of its backlog revenue by the end of 2025 and is pursuing growth through strategic investments and acquisitions.

Industry Context

BWXT operates in the nuclear components and fuel, technical services, and medical radioisotope industries, competing with companies specializing in nuclear capabilities and nuclear medicine.

Comparison to Industry Standards

• BWXT competes with companies such as Bechtel National, Inc., Fluor Corporation, Jacobs Engineering Group, Inc., Northrop Grumman Corporation, Huntington Ingalls Industries, Inc., Honeywell International, Inc., Leidos, Inc., Westinghouse Electric Corporation and AtkinsRalis in the delivery of goods and services to the U.S. Government and the operation of U.S. Government facilities.
• BWXT competes with companies such as Framatome, Cameco Corporation, Doosan Heavy Industries & Construction Co., Ltd., E.S. Fox Limited, AECON Group Inc., Bechtel National, Inc., Westinghouse Electric Corporation and AtkinsRalis in the supply of heavy nuclear components, specialized engineering and maintenance services, nuclear fuel, fuel handling systems and tooling delivery systems for CANDU reactors.
• BWXT competes with companies such as Curium Pharma, Lantheus Holdings, Inc. and Jubilant DraxImage Inc. in the manufacture of medical radioisotopes, radiopharmaceuticals and medical devices.

Stakeholder Impact

• Shareholders: The company's increased revenue and backlog, along with strategic acquisitions, could lead to increased shareholder value.
• Employees: The company's focus on human capital management, including employee development, diversity and inclusion, and health and safety, could lead to a more positive work environment.
• Customers: The company's increased capabilities and expanded product and service offerings could lead to improved customer satisfaction.
• Suppliers: The company's reliance on a limited number of suppliers could create risks for those suppliers.
• Creditors: The company's strong financial position and access to debt markets could provide assurance to creditors.

Next Steps

• Complete the acquisition of Kinectrics, Inc. in mid-2025.
• Continue to pursue growth strategies through strategic investments and acquisitions.
• Continue to develop and commercialize new technologies to support growth.
• Prepare for certification under the Cybersecurity Maturity Model Certification (CMMC) program.

Key Dates

Keywords

nuclear, components, fuel, government, operations, commercial, backlog, revenue, acquisition, contracts, BWXT